Calithera Biosciences, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€308.10K - Gross profit
-€308.10K - SG&A expenses
€11.69M - R&D expenses
€24.63M - EBITDA
-€36.15M - D&A
-€1.71M - EBIT
-€36.31M - Interest expenses
€66.45K - EBT
-€34.22M - Tax expenses
-€16.41M - Net income
-€17.57M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€1.10M - Changes in working capital
-€6.41M - Operating cash flow
-€37.64M - Capex
€114.78K - Other investing cash flow
€0.00 - Net investing cash flow
-€114.78K - Total cash dividends paid
€0.00 - Issuance of common stock
€15.64M - Debt repayment
€0.00 - Other financing cash flow
€13.81K - Net financing cash flow
€8.33M - Foreign exchange effects
€0.00 - Net change in cash
-€29.42M - Cash at end of period
€22.20M - Free cash flow
-€37.52M
Balance sheet
- Cash and cash equivalents
€21.97M - Cash and short-term investments
€21.97M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€1.01M - Total current assets
€22.98M - Property, plant & equipment
€1.54M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€233.02K - Total non-current assets
€1.77M - Total assets
€24.75M - Accounts payable
€631.74K - Short-term debt
€1.32M - Other current liabilities
€4.43M - Total current liabilities
€6.38M - Long-term debt
€117.37K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€654.18K - Total non-current liabilities
€771.55K - Total liabilities
€7.15M - Common stock
€0.00 - Retained earnings
-€442.41M - Other equity
€0.00 - Total equity
€17.60M - Total liabilities and shareholders' equity
€24.75M
Company information
- Market capitalization
€415.39 - Employees
8 - Enterprise Value
-€23.78M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-99.9% Much worse than peer group: -48.7% - ROA
-
-71.0% Much better than peer group: -127.0% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-9,087,921.1% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€2.20M